Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jiří Eitler
Observed names:
Eitler J,
Eitler, Jiri,
Eitler, Jiří,
J Eitler,
J. Eitler,
Jiri Eitler
show all 6
Institutions:
German Red Cross,
Deutsches Konsortium für Translationale Krebsforschung,
German Cancer Consortium (DKTK) Dresden,
Technische Universität Dresden
Observed institutions:
Czech Academy of Sciences,
German Red Cross,
Czech Academy of Sciences, Institute of Molecular Genetics,
University Hospital Carl Gustav Carus,
Deutsches Konsortium für Translationale Krebsforschung,
German Cancer Consortium (DKTK) Dresden,
Technische Universität Dresden
show all 7
ORCID:
0000-0002-3175-2438
Observed ORCID:
0000-0002-3175-2438
OpenAlex ID:
A5055665904
Developmental origin, functional maintenance and genetic rescue of osteoclasts
2019
·
Christian E. Jacome-Galarza
, Gulce I. Percin
, et al.
·
Nature
·
491
“UniCAR”-modified off-the-shelf NK-92 cells for targeting of GD2-expressing tumour cells
2020
·
Nicola Mitwasi
, Anja Feldmann
, et al.
·
Scientific Reports
·
86
PDF
Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo
2023
·
Renata Nacasaki Silvestre
, Jiri Eitler
, et al.
·
Frontiers in Immunology
·
67
PDF
CSF1R regulates the dendritic cell pool size in adult mice via embryo-derived tissue-resident macrophages
2018
·
Gulce Itir Percin
, Jiri Eitler
, et al.
·
Nature Communications
·
49
PDF
CAR-mediated targeting of NK cells overcomes tumor immune escape caused by ICAM-1 downregulation
2024
·
Jiri Eitler
, Wiebke Rackwitz
, et al.
·
Journal for ImmunoTherapy of Cancer
·
44
PDF
1,2-propanediol-trehalose mixture as a potent quantitative real-time PCR enhancer
2011
·
Helena Horáková
, Iva Polakovičová
, et al.
·
BMC Biotechnology
·
44
PDF
Inability of granule polarization by NK cells defines tumor resistance and can be overcome by CAR or ADCC mediated targeting
2021
·
Jiri Eitler
, Natalie Wotschel
, et al.
·
Journal for ImmunoTherapy of Cancer
·
38
PDF
C/EBPβ-dependent autophagy inhibition hinders NK cell function in cancer
2024
·
Federica Portale
, Roberta Carriero
, et al.
·
Nature Communications
·
32
PDF
Preclinical assessment of CAR-NK cell-mediated killing efficacy and pharmacokinetics in a rapid zebrafish xenograft model of metastatic breast cancer
2023
·
Nivedha Murali Shankar
, Paola Ortiz Montero
, et al.
·
Frontiers in Immunology
·
22
Radiation-induced morphea of the breast – characterization and treatment of fibroblast dysfunction with repurposed mesalazine
2024
·
Stephan R. Künzel
, Erik Klapproth
, et al.
·
Scientific Reports
·
7
PDF
Developmental origin, functional maintenance and genetic rescue of osteoclasts
2019
·
Jacome-Galarza CE
, Percin GI
, et al.
·
Yearbook of pediatric endocrinology
·
5
Dual CAR-NK cells targeting PD-L1 and ErbB2 (HER2) exhibit cooperative CAR signaling and counteract solid tumor heterogeneity
2026
·
Kristin Freudenberg-Jahn
, Idan Ben-Horin
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
4
Translational development and first-in-human compassionate infusion of NK-92 cells expressing a CD5-based chimeric antigen receptor (SRCD5CAR-NK-92) in a patient with multidrug-resistant fusariosis
2026
·
María Velasco-de-Andrés
, Pedro Puerta-Alcalde
, et al.
·
Frontiers in Immunology
·
2
256 Dual targeting of PD-L1 and ErbB2 by CAR-NK cells enables specific elimination of solid tumor cells and overcomes immune escape via antigen loss
2024
·
Jiri Eitler
, Idan Ben-Horin
, et al.
·
Journal for ImmunoTherapy of Cancer
·
2
Car-mediated Targeting of Nk Cells Overcomes Tumor Immune Escape Caused by Icam-1 Downregulation
2024
·
J. Eitler
, W. Rackwitz
, et al.
·
Cytotherapy
·
2
Application of chimeric antigen receptor-natural killer cells for the treatment of type 1 diabetes
2023
·
Charlotte Steenblock
, Jiri Eitler
, et al.
·
2
PDF
216 Dual targeting of CAR-NK cells to PD-L1 and ErbB2 facilitates specific elimination of cancer cells of solid tumor origin and overcomes immune escape by antigen loss
2022
·
Jiri Eitler
, Kristin Freudenberg
, et al.
·
Journal for ImmunoTherapy of Cancer
·
2
PDF
Dual-CAR NK cells targeting PD-L1 and ErbB2/HER2 eliminate solid tumor cells and prevent immune escape due to antigen loss
2025
·
J. Eitler
, I. Ben-Horin
, et al.
·
Cytotherapy
·
1
FAPα-TARGETED IMMUNOTHERAPY WITH SIBROTUZUMAB AND HIGH AFFINITY FC-RECEPTOR EXPRESSING NK92 CELLS: A PROMISING APPROACH TO REVERSE FIBROSIS
2024
·
S.R. Kuenzel
, M. Arriens
, et al.
·
Cytotherapy
·
1
Immunotherapy: Late Breaking Abstract: CD19-CAR NK CELLS CO-EXPRESSING IL15/IL15Rα SHOW ENHANCED CYTOTOXICITY AGAINST B-CELL LEUKEMIA
2022
·
R.N. Silvestre
, J. Eitler
, et al.
·
Cytotherapy
·
1
Promoter Choice: the Ideal Promoter to Drive Chimeric Antigen Receptor (car) Expression in Nk Cells
2021
·
RN Silvestre
, J Eitler
, et al.
·
Hematology Transfusion and Cell Therapy
·
1
PDF
Live cell imaging of lytic granule motility in anti-ErbB2 CAR NK cells and FcR NK cells plus Herceptin towards ErbB2+ breast cancer cells
2020
·
J. Eitler
, N. Wotschel
, et al.
·
Cytotherapy
·
1
Additional file 1 of Dual CAR-NK cells targeting PD-L1 and ErbB2 (HER2) exhibit cooperative CAR signaling and counteract solid tumor heterogeneity
2026
·
Freudenberg-Jahn, Kristin
, Ben-Horin, Idan
, et al.
·
Figshare
Dual CAR-NK cells targeting PD-L1 and ErbB2 (HER2) exhibit cooperative CAR signaling and counteract solid tumor heterogeneity
2026
·
Freudenberg-Jahn, Kristin
, Ben-Horin, Idan
, et al.
·
Figshare
Caar-nk Cell-mediated Selective Elimination of Autoreactive B Cells in Pemphigus Vulgaris
2026
·
M. Arriens
, L. Zimmermann
, et al.
·
Cytotherapy
Show more works
View as search
Works count:
36
Citation count:
904
H-index:
9
I10-index:
9
Year
Topic
Type